Gamida Cell raised €7.6M in a Series D+ round in May 2012. The company is based in Jerusalem, Israel. Investors in the round: Amgen, Auriga Partners. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
